{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:21:16Z","timestamp":1790713276814,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100018430","name":"Fondazione Istituto Europeo di Oncologia e Centro Cardiologico Monzino","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018430","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ijrobp.2018.03.058","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T13:18:59Z","timestamp":1522847939000},"page":"650-660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday"],"prefix":"10.1016","volume":"101","author":[{"given":"Roberta","family":"Lazzari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Surgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0498-2964","authenticated-orcid":false,"given":"Stefania","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Piperno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Pansini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Fodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Orecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Tomao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Parma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Alicja","family":"Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.03.058_bib1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/IGC.0000000000000958","article-title":"Recurrent ovarian cancer: The role of radiation therapy","volume":"27","author":"De Felice","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ygyno.2013.04.469","article-title":"Involved-field radiation therapy for locoregionally recurrent ovarian cancer","volume":"130","author":"Brown","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/IGC.0000000000000653","article-title":"Long-term benefit of tumor volume-directed involved field radiation therapy in the management of recurrent ovarian cancer","volume":"26","author":"Albuquerque","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2016.02.005","article-title":"Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapy","volume":"141","author":"Chundury","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jrr\/rrs108","article-title":"Epithelial ovarian cancer: Definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy","volume":"54","author":"Yahara","year":"2013","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/ijgc-00009577-200205000-00003","article-title":"Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy","volume":"12","author":"Fujiwara","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000357269","article-title":"Radiation therapy for chemotherapy-resistant recurrent epithelial ovarian cancer","volume":"86","author":"Machida","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/030089161109700509","article-title":"Radiation therapy is a treatment to be considered for recurrent epithelial ovarian cancer after chemotherapy","volume":"97","author":"Lee","year":"2011","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1634\/theoncologist.2012-0092","article-title":"Review and uses of stereotactic body radiation therapy for oligometastases","volume":"17","author":"Alongi","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ijrobp.2011.08.036","article-title":"Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study","volume":"83","author":"Milano","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1748-717X-9-135","article-title":"Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence","volume":"9","author":"Decaestecker","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib14","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1016\/j.clgc.2017.01.004","article-title":"Salvage stereotactic body radiotherapy for isolated lymph node recurrent prostate cancer: Single institution series of 94 consecutive patients and 124 lymph nodes","volume":"15","author":"Jereczek-Fossa","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/COC.0b013e3182610878","article-title":"Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer","volume":"37","author":"Jereczek-Fossa","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.rpor.2014.10.004","article-title":"Is stereotactic body radiotherapy (SBRT) in lymph node oligometastatic patients feasible and effective?","volume":"20","author":"Jereczek-Fossa","year":"2015","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4329\/wjr.v6.i6.366","article-title":"Use of stereotactic radiosurgery in the treatment of gynecologic malignancies: A review","volume":"6","author":"Long","year":"2014","journal-title":"World J Radiol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2010.11.042","article-title":"Stereotactic body radiotherapy (SBRT): Technological innovation and application in gynecologic oncology","volume":"120","author":"Higginson","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/153303460900800510","article-title":"Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies","volume":"8","author":"Kunos","year":"2009","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fonc.2012.00181","article-title":"Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies","volume":"2","author":"Kunos","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fonc.2015.00126","article-title":"Phase I trial of carboplatin and gemcitabine chemotherapy and stereotactic ablative radiosurgery for the palliative treatment of persistent or recurrent gynecologic cancer","volume":"5","author":"Kunos","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/IGC.0000000000000869","article-title":"Clinical outcomes for stereotactic ablative radiotherapy in oligometastatic and oligoprogressive gynecological malignancies","volume":"27","author":"Mesko","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","article-title":"An overview of hypofractionation and introduction to this issue of seminars in radiation oncology","volume":"18","author":"Timmerman","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib26","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib28","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1080\/0284186X.2017.1346383","article-title":"Oligometastatic cancer: Stereotactic ablative radiotherapy for patients affected by isolated body metastasis","volume":"56","author":"Lancia","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clgc.2012.08.003","article-title":"Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: Deferring androgen deprivation therapy","volume":"11","author":"Berkovic","year":"2013","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib30","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/bjc.2017.103","article-title":"Efficacy of stereotactic body\u00a0radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study","volume":"116","author":"Triggiani","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ctrv.2016.11.003","article-title":"The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?","volume":"52","author":"Hong","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.semradonc.2008.04.004","article-title":"The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction","volume":"18","author":"Brenner","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib33","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1002\/cncr.26611","article-title":"Stereotactic body radiotherapy for multisite extracranial oligometastases: Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease","volume":"118","author":"Salama","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1245\/s10434-010-1405-5","article-title":"Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases","volume":"18","author":"Rule","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.058_bib35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.prro.2012.08.006","article-title":"Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease","volume":"3","author":"Corbin","year":"2013","journal-title":"Pract Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618306096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618306096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T19:10:17Z","timestamp":1656443417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618306096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0360301618306096"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.03.058","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.03.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}